Procaps Group S.A. (PROC)
NASDAQ: PROC · IEX Real-Time Price · USD
2.710
+0.110 (4.23%)
At close: Apr 19, 2024, 12:16 PM
2.830
+0.120 (4.43%)
After-hours: Apr 19, 2024, 4:00 PM EDT
Procaps Group Market Cap
Procaps Group has a market cap or net worth of $305.75 million as of April 19, 2024. Its market cap has decreased by -41.59% in one year.
Market Cap
305.75M
Enterprise Value
573.96M
1-Year Change
-41.59%
Ranking
Category
Stock Price
$2.71
Market Cap Chart
Since October 18, 2019, Procaps Group's market cap has increased from $220.90M to $305.75M, an increase of 38.41%. That is a compound annual growth rate of 7.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 18, 2024 | 304.60M | 0.73% |
| Apr 17, 2024 | 302.40M | 4.71% |
| Apr 16, 2024 | 288.80M | -1.53% |
| Apr 15, 2024 | 293.30M | -3.36% |
| Apr 12, 2024 | 303.50M | -0.03% |
| Apr 11, 2024 | 303.60M | 1.54% |
| Apr 10, 2024 | 299.00M | 1.94% |
| Apr 9, 2024 | 293.30M | -1.91% |
| Apr 8, 2024 | 299.00M | -7.00% |
| Apr 5, 2024 | 321.50M | - |
| Apr 4, 2024 | 321.50M | 1.77% |
| Apr 3, 2024 | 315.90M | 0.70% |
| Apr 2, 2024 | 313.70M | -4.45% |
| Apr 1, 2024 | 328.30M | 0.34% |
| Mar 28, 2024 | 327.20M | 4.30% |
| Mar 27, 2024 | 313.70M | -7.35% |
| Mar 26, 2024 | 338.60M | 0.03% |
| Mar 25, 2024 | 338.50M | -3.37% |
| Mar 22, 2024 | 350.30M | - |
| Mar 21, 2024 | 350.30M | - |
| Mar 20, 2024 | 350.30M | -2.67% |
| Mar 19, 2024 | 359.90M | -1.85% |
| Mar 18, 2024 | 366.70M | 3.50% |
| Mar 15, 2024 | 354.30M | - |
| Mar 14, 2024 | 354.30M | -0.23% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AirSculpt Technologies | 312.38M |
| Clover Health Investments | 311.45M |
| Atea Pharmaceuticals | 311.41M |
| Sera Prognostics | 307.97M |
| Anavex Life Sciences | 307.18M |
| Rani Therapeutics Holdings | 303.45M |
| TScan Therapeutics | 301.75M |
| Viemed Healthcare | 300.21M |